Peptic Ulcer Disease (PUD), Diagnosis, and Current Medication-Based Management Options: Schematic Overview

Yash Srivastav, Vijay Kumar, Yashi Srivastava, Madhaw Kumar
{"title":"Peptic Ulcer Disease (PUD), Diagnosis, and Current Medication-Based Management Options: Schematic Overview","authors":"Yash Srivastav, Vijay Kumar, Yashi Srivastava, Madhaw Kumar","doi":"10.9734/jamps/2023/v25i11651","DOIUrl":null,"url":null,"abstract":"A common condition in the world, Peptic Ulcer condition is sometimes referred to as stomach ulcers or peptic ulcers. PUD is caused by a defect in the mucosa of the stomach or duodenum that extends beyond the muscularis mucosa. PUD is the consequence of an imbalance between the aggressive and defensive elements impacting the mucosa, which occurs after gastric mucosal lesions. Peptic ulcer disease (PUD) is a widespread ailment affecting 5–10% of the world's population, with notable racial and regional variations. As a result of an imbalance between the aggressive and defensive elements impacting the mucosa, comes gastric mucosal injuries. The word \"peptic\" comes from the hormone pepsin, which is essential in causing mucosal breakdown. The most common cause of upper gastrointestinal bleeding in the Western world is bleeding from peptic ulcers (PUs). High rates of morbidity, mortality, and medical costs are linked to it. This review article covers the pathophysiology, aetiology, medical therapy, diagnosis, symptoms, and signs of Peptic Ulcer Disease (PUD).","PeriodicalId":14903,"journal":{"name":"Journal of Advances in Medical and Pharmaceutical Sciences","volume":"36 12","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Advances in Medical and Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9734/jamps/2023/v25i11651","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

A common condition in the world, Peptic Ulcer condition is sometimes referred to as stomach ulcers or peptic ulcers. PUD is caused by a defect in the mucosa of the stomach or duodenum that extends beyond the muscularis mucosa. PUD is the consequence of an imbalance between the aggressive and defensive elements impacting the mucosa, which occurs after gastric mucosal lesions. Peptic ulcer disease (PUD) is a widespread ailment affecting 5–10% of the world's population, with notable racial and regional variations. As a result of an imbalance between the aggressive and defensive elements impacting the mucosa, comes gastric mucosal injuries. The word "peptic" comes from the hormone pepsin, which is essential in causing mucosal breakdown. The most common cause of upper gastrointestinal bleeding in the Western world is bleeding from peptic ulcers (PUs). High rates of morbidity, mortality, and medical costs are linked to it. This review article covers the pathophysiology, aetiology, medical therapy, diagnosis, symptoms, and signs of Peptic Ulcer Disease (PUD).
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
消化性溃疡病 (PUD)、诊断和当前的药物治疗方案:示意图概述
消化性溃疡是世界上常见的一种疾病,有时也被称为胃溃疡或消化性溃疡。PUD是由胃或十二指肠粘膜的缺损引起的,它超出了肌层黏膜。PUD是胃粘膜病变后侵袭性和防御性因素影响粘膜失衡的结果。消化性溃疡病(PUD)是一种广泛存在的疾病,影响世界人口的5-10%,具有显著的种族和地区差异。由于影响粘膜的侵袭性和防御性因素之间的不平衡,导致胃粘膜损伤。“消化性的”这个词来自于一种叫做胃蛋白酶的激素,它是导致粘膜破裂的关键。在西方世界,上消化道出血最常见的原因是消化性溃疡出血。高发病率、高死亡率和高医疗费用都与之相关。本文综述了消化性溃疡病(PUD)的病理生理、病因、药物治疗、诊断、症状和体征。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Evaluating Compliance and Performance of 0.5 mL AD Syringes: A Global Standards Review Acute Toxicity, Antioxidant and Vasodilatory Properties of Sclerocarya birrea (A. rich.) Hochst (Anacardiaceae) Trunk Bark’s Aqueous Decoction Towards Effective Healthcare Delivery: An Assessment of Public Perception of Pharmacist’s Role in Nigeria Multiple Drug Resistance in Burn Patients In-Process Quality Checks and Post-Market Surveillance of Artemether-Lumefantrine Fixed-dose Combination Tablets and Suspensions: Current Procedures, Successes, Advances, and Challenges
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1